Zoetis | ZTS - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.53B 4.47B 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Dentsply International USD 1.85B 178M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Henry Schein USD 4.5B 32M 2026-03
Idexx Laboratories USD 1.45B 40.25M 2026-03
Illumina USD 2.74B 551M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
J&J USD 59.17B 3.55B 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Merck USD 35.02B 8.5B 2026-03
Neogen USD 590M 15.42M 2025-12
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
Zoetis USD 6.47B 294M 2026-03